徐亚威,许浩杰,孟圆,杨海波

• 1:郑州大学第一附属医院心内科

摘要(Abstract)：

目的 探讨使用血管内超声（IVUS）评估经皮冠状动脉腔内冲击波球囊导管成形术（IVL）应用于钙化小结的有效性及安全性。方法 共纳入2023年1月1日至5月31日郑州大学第一附属医院14例严重钙化患者，按有无钙化小结分为钙化小结组（8例）、无钙化小结组（6例）。对15支血管进行了IVL预处理，钙化小结血管组8支，无钙化小结血管组7支。患者均有IVL使用前及支架置入后的IVUS影像。主要有效性终点，在病变水平分析，钙化小结处与钙化角度最大处，支架置入后支架膨胀情况。次要有效性终点，在血管水平分析，比较钙化小结组与无钙化小结组支架置入术后的最小支架内面积。安全性终点，在支架置入术中有无介入并发症，包括严重血管夹层、血管急性闭塞、血管穿孔、慢血流、球囊破裂。结果 在病变水平分析，对15支血管中的钙化病变进一步分组，病变中钙化小结有8处（钙化小结病变组），钙化角度最大处有15处（钙化角度最大病变组）。IVL使用前，钙化小结病变组管腔面积高于钙化角度最大病变组[3.68(3.19,5.13)mm~2比2.84(2.07,3.15)mm~2,P=0.026]，钙化小结病变组支架置入后同样部位面积增加低于钙化角度最大病变组[（2.43±1.65）mm~2比（4.57±1.75）mm~2,P=0.009]，但两组支架对称性、支架置入后管腔面积及支架膨胀系数比较，差异均无统计学意义（均P>0.05）。在血管水平分析，钙化小结血管组（7支）与无钙化小结血管组（6支）在支架置入后最小支架内面积比较，差异无统计学意义（P=0.578）。两组患者均无介入并发症发生。结论 IVL对于钙化小结病变可以充分预处理，进而保证支架的膨胀及对称性，术中无严重介入并发症出现。IVL治疗钙化小结安全有效。

关键词(KeyWords)： 经皮冠状动脉介入治疗;钙化小结;冲击波球囊导管成形术;血管内超声

Abstract:

Keywords:

基金项目(Foundation): 河南省医学科技攻关计划联合共建项目（LHGJ20220274）

作者(Author): 徐亚威,许浩杰,孟圆,杨海波

参考文献(References)：

• [1] Zaidan M, Alkhalil M, Alaswad K. Calcium modification therapies in contemporary percutaneous coronary intervention[J].Curr Cardiol Rev, 2022,18(1):e281221199533. DOI:10.2174/1573403X18666211228095457.
• [2] Blachutzik F,Honton B,Escaned J,et al. Safety and ef fectiveness of coronary intravascular lithotripsy in eccentric calcifi ed coronary lesions:a patient-level pooled analysis from the Disrupt CADⅠand CADⅡStudies[J]. Clin Res Cardiol,2021,110(2):228-236. DOI:10.1007/s00392-020-01737-3.
• [3] Ali ZA,Kereiakes D,Hill J,et al. Safety and ef fectiveness of coronary intravascular lithotripsy for treatment of calcifi ed nodules[J].JACC Cardiovasc Interv,2023,16(9):1122-1124. DOI:10.1016/j.jcin.2023.02.015.
• [4] Lee JB,Mintz GS,Lisauskas JB,et al. Histopathologic validation of the intravascular ultrasound diagnosis of calcified coronary artery nodules[J]. Am J Cardiol,2011,108(11):1547-1551. DOI:10.1016/j.amjcard.2011.07.014.
• [5] Zhang M,Matsumura M,Usui E,et al. Intravascular ultrasound-derived calcium score to predict stent expansion in severely calcified lesions[J]. Circ Cardiovasc Interv, 2021, 14(10):e10296. DOI:10.1161/CIRCINTERVENTIONS.120.010296.
• [6] Brinton TJ,Ali ZA,Hill JM,et al. Feasibility of shockwave coronary intravascular lithotripsy for the treatment of calcified coronary stenoses[J]. Circulation,2019,139(6):834-836. DOI:10.1161/CIRCULATIONAHA.118.036531.
• [7] Ali ZA,Nef H,Escaned J,et al. Safety and Effectiveness of coronary intravascular lithotripsy for treatment of severely calcifi ed coronary stenoses:the disrupt CADⅡstudy[J]. Circ Cardiovasc Interv,2019,12(10):e008434. DOI:10.1161/CIRCINTERVENTIONS.119.008434.
• [8] Hill JM,Kereiakes DJ,Shlofmitz RA,et al. Intravascular lithotripsy for treatment of severely calcified coronary artery disease the disrupt CADⅢstudy[J]. J Am Coll Cardiol,2020,76(22):2635-2646. DOI:10.1016/j.jacc.2020.09.603.
• [9] Saito S,Yamazaki S,Takahashi A,et al. Intravascular lithotripsy for vessel preparation in severely calcified coronary arteries prior to stent placement-primary outcomes from the japanese disrupt CADⅣstudy[J]. Circ J,2021,85(6):826-833. DOI:10.1253/circj.CJ-20-1174.
• [10] Emori H,Shiono Y,Kuriyama N,et al. Calcium fracture after intravascular lithotripsy as assessed with optical coherence tomography[J]. Circ J, 2023,87(6):799-805. DOI:10.1253/circj.CJ-22-0695.
• [11] Bhogal S,Garcia-Garcia HM,Klein A,et al. Intravascular lithotripsy for the treatment of severely calcifi ed coronary artery disease:a disrupt CADⅢintravascular ultrasound substudy[J].Cardiovasc Revasc Med,2023,53:22-27. DOI:10.1016/j.carrev.2023.03.003.
• [12] Nozoe M,Nishioka S,Oi K,et al. Effects of patient background and treatment strategy on clinical outcomes after coronary intervention for calcified nodule lesions[J]. Circ Rep,2021,3(12):699-706. DOI:10.1253/circrep.CR-21-0129.
• [13]曹成富，王伟民，刘健，等.钙化结节对行冠状动脉斑块旋磨术的严重钙化病变患者长期预后的影响[J].中国介入心脏病学杂志，2023,31(3):182-186. DOI:10.3969/j.issn.1004-8812.2023.03.003.
• [14] Jinnouchi H,Sakakura K,Taniguchi Y,et al. Clinical outcomes and unique restenosis of calcified nodule in heavily calcified coronary artery[J]. J Atheroscler Thromb,2023,30(6):649-662. DOI:10.5551/jat.63667.
• [15]温尚煜，尚瑞平，于宏颖，等.冠状动脉内旋磨术并发症分析、预防及处理技巧[J].中国介入心脏病学杂志，2017,25(12):677-681. DOI:10. 3969/j. issn. 1004-8812. 2017.12. 004.
• [16]曹成富，马玉良，李琪，等.光学相干断层成像指导钙化病变介入治疗策略[J].中国介入心脏病学杂志，2021,29(6):345-349. DOI:10.3969/j.issn.1004-8812.2021.06.011.
• [17] Wang X,Matsumura M,Mintz GS,et al. In vivo calcium detection by comparing optical coherence tomography,intravascular ultrasound,and angiography[J]. JACC Cardiovasc Imaging,2017,10(8):869-879. DOI:10.1016/j.jcmg.2017.05.014.
• [18] Hong MK,Mintz GS,Lee CW,et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation[J]. Eur Heart J,2006,27(11):1305-1310.DOI:10.1093/eurheartj/ehi882.
• [19] Zhang J,Gao X,Kan J,et al. Intravascular ultrasound versus angiography-guided drug-eluting stent implantation:the ULTIMATE trial[J]. J Am Coll Cardiol,2018,72(24):3126-3137. DOI:10.1016/j.jacc.2018.09.013.